摘要
回顾性分析解放军总医院2010年1月至2020年12月收治的61例唾液腺导管癌患者临床资料, 其中男55例(90.2%), 女6例(9.8%);50岁以上者占83.6%(51例);大多数原发肿瘤来自腮腺(73.8%, 45例);57.4%(35例)的患者发生了颈部淋巴结转移, 41.0%(25例)的患者出现远处转移;所有患者均接受了手术治疗, 术后有50例患者(82.0%)接受了辅助放疗;患者3、5年生存率分别为58.0%和43.3%, 术后辅助放疗及放化疗患者的生存率高于仅手术的患者。可见, 对于唾液腺导管癌, 根治性手术治疗是必要的, 术后放化疗可以一定程度上降低复发率, 提高生存率。
The clinical data of 61 patients of salivary duct carcinoma admitted to the First Medical Centre of Chinese PLA General Hospital from January 2010 to December 2020 were retrospectively reviewed.A total of 55 patients(90.2%)were male and 6(9.8%)were female.There were 51 patients(83.6%)aged≥50 years.The primary tumor of 45 patients(73.8%)were from the parotid gland.There were 35 patients(57.4%)who had cervical lymph node metastasis and 25 patients(41.0%)had distant metastasis.All patients underwent surgery and 50 of them(82.0%)received adjuvant radiotherapy.The 3-year and 5-year survival rates were 58.0%and 43.3%,respectively.Compared with the patients who had undergone surgery only,the survival rates of those who had postoperative adjuvant radiotherapy and chemoradiotherapy were higher.It can be seen that radical surgical treatment is necessary,and postoperative radiotherapy can reduce the recurrence rate and increase the survival rate to a certain extent.
作者
陈飞
王利伟
布静秋
Chen Fei;Wang Liwei;Bu Jingqiu(Department of Stomatology,the First Medical Centre of Chinese PLA General Hospital,Beijing 100853,China)
出处
《中华医学杂志》
CAS
CSCD
北大核心
2022年第18期1394-1397,共4页
National Medical Journal of China
关键词
唾液腺
唾液腺导管癌
唾液腺肿瘤
唾液腺癌
Salivary gland
Salivary duct carcinoma
Salivary gland tumors
Malignant tumor of salivary gland
